Clinical Trial Update: Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR)

View source ↗

Summary

The Clinical Performance Evaluation trial (CLEAR) for the Cholestech LDX Cardiac hsCRP Test has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Cardiovascular Disease | Status: WITHDRAWN